IPSIndian Journal of Pharmacology
Home  IPS  Feedback Subscribe Top cited articles Login 
Users Online : 2829 
Small font sizeDefault font sizeIncrease font size
Read this article


    Article Cited by others


Comparative evaluation of efficacy and tolerability of vilazodone, escitalopram, and amitriptyline in patients of major depressive disorder: A randomized, parallel, open-label clinical study

Kadam Renuka L, Sontakke Smita Dipak, Tiple Prashant, Motghare Vijay M, Bajait Chaitali S, Kalikar Mrunalini V

Year : 2020| Volume: 52| Issue : 2 | Page no: 79-85

   This article has been cited by
1 An Open-Label Rater-Blinded Randomized Trial of Vilazodone versus Escitalopram in Major Depression
Pattath Narayanan Suresh Kumar, Rohith Suresh, Vikas Menon
Indian Journal of Psychological Medicine. 2022; : 0253717622
[Pubmed]  [Google Scholar] [DOI]
2 Vilazodone for Major Depression in Adults: Pharmacological Profile and an Updated Review for Clinical Practice
Mohit Chauhan, Rebecca Parry, William V Bobo
Neuropsychiatric Disease and Treatment. 2022; Volume 18: 1175
[Pubmed]  [Google Scholar] [DOI]
3 Risks of Digestive System Side-Effects of Selective Serotonin Reuptake Inhibitors in Patients with Depression: A Network Meta-Analysis
Zhuoyue Wang, Hui Li, Yimin Kang, Yanlong Liu, Ligang Shan, Fan Wang
Therapeutics and Clinical Risk Management. 2022; Volume 18: 799
[Pubmed]  [Google Scholar] [DOI]


Site Map | Home | Contact Us | Feedback | Copyright and Disclaimer | Privacy Notice
Online since 20th July '04
Published by Wolters Kluwer - Medknow